Children with non-curative brain tumors have a predictable and burdensome neurological decline. Care provision for these children falls in the gap where the acute inpatient services intersect with community-based providers. These children commonly receive care in the community; however, their neurological decline often outpaces engagement with community-based providers. Children with non-curative brain tumors are commonly referred to specialist palliative care services and need timely availability and access to this support. The purpose of this scoping review was to explore the evidence related to standards, guidelines, and models of palliative care provision for children with non-curative brain tumors, and to examine the facilitators and barriers to the implementation of, and access to, these services. Using a narrative synthesis method, a scoping review was conducted according to the Joanna Briggs Institute methodology using six electronic databases (Medline, Embase, Web of Science, Pubmed, CINAHL, and Cochrane Database of Systematic Reviews) from January 2013 to May 2023. A total of 2404 studies were screened for eligibility and 31 were selected for data extraction. There are no international models or standards of care for providing palliative care for children with non-curative brain tumors. Instead, palliative care is delivered at an institutional level, potentially leading to variability in the care that is provided. This variability can threaten the quality of life of these children and their families. Variability in care provision could be minimized by development of standardized palliative care provision. Any proposed standard for palliative care provision for children with non-curative brain tumors should include early integration of palliative care, and allocation of resources to enable training to operationalize referrals to palliative care teams and multidisciplinary care provision across settings, especially home-based care.
PollackIF. Brain tumors in children. N Engl J Med, 1994; 331(22):1500–1507; doi: 10.1056/nejm199412013312207
2.
StillerCA, NectouxJ. International incidence of childhood brain and spinal tumours. Int J Epidemiol, 1994; 23(3):458–464; doi: 10.1093/ije/23.3.458
3.
Steliarova-FoucherE, ColombetM, RiesLAG, et al.; IICC-3 contributors. International incidence of childhood cancer, 2001-10: A population-based registry study. Lancet Oncol, 2017; 18(6):719–731; doi: 10.1016/s1470-2045(17)30186-9
4.
StanićD, GrujičićD, PekmezovićT, et al.Clinical profile, treatment and outcome of pediatric brain tumors in Serbia in a 10-year period: A national referral institution experience. PLoS One, 2021; 16(10):e0259095; doi: 10.1371/journal.pone.0259095
5.
JansenMH, van VuurdenDG, VandertopWP, et al.Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology. Cancer Treat Rev, 2012; 38(1):27–35; doi: 10.1016/j.ctrv.2011.06.007
6.
HossainMJ, XiaoW, TayebM, et al.Epidemiology and prognostic factors of pediatric brain tumor survival in the US: Evidence from four decades of population data. Cancer Epidemiol, 2021; 72:101942; doi: 10.1016/j.canep.2021.101942
7.
NapieralskaA, KrzywonA, Mizia-MalarzA, et al.High-grade gliomas in children-a multi-institutional polish Study. Cancers (Basel), 2021; 13(9); doi: 10.3390/cancers13092062
8.
HargraveD, BartelsU, BouffetE. Diffuse brainstem glioma in children: Critical review of clinical trials. Lancet Oncol, 2006; 7(3):241–248; doi: 10.1016/s1470-2045(06)70615-5
9.
LangmoenIA, LundarT, Storm-MathisenI, et al.Management of pediatric pontine gliomas. Childs Nerv Syst, 1991; 7(1):13–15; doi: 10.1007/bf00263825
10.
JangSW, SongSW, KimY-H, et al.Clinical features and prognosis of diffuse midline glioma: A series of 24 cases. Brain Tumor Res Treat, 2022; 10(4):255–264.
11.
ZelcerS, CataudellaD, CairneyAEL, et al.Palliative care of children with brain tumors: A parental perspective. Arch Pediatr Adolesc Med, 2010; 164(3):225–230; doi: 10.1001/archpediatrics.2009.284
12.
Veldhuijzen van ZantenSE, van MeerwijkCL, JansenMH, et al.; SIOPE DIPG Network. Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: Results from a London cohort study and international survey. Neuro Oncol, 2016; 18(4):582–588; doi: 10.1093/neuonc/nov250
13.
ApplebaumAJ, Kryza-LacombeM, ButhornJ, et al.Existential distress among caregivers of patients with brain tumors: A review of the literature. Neurooncol Pract, 2016; 3(4):232–244; doi: 10.1093/nop/npv060
14.
MassieAM, EbelharJ, AllenKE, et al.Defining and timing of palliative opportunities in children with central nervous system tumors. Neurooncol Pract, 2021; 8(4):451–459; doi: 10.1093/nop/npab020
15.
ChongPH, De Castro MolinaJA, TeoK, et al.Paediatric palliative care improves patient outcomes and reduces healthcare costs: Evaluation of a home-based program. BMC Palliat Care, 2018; 17(1):11; doi: 10.1186/s12904-017-0267-z
16.
JohnstonDL, NagelK, FriedmanDL, et al.Availability and use of palliative care and end-of-life services for pediatric oncology patients. J Clin Oncol, 2008; 26(28):4646–4650; doi: 10.1200/jco.2008.16.1562
17.
FraserLK, van LaarM, MillerM, et al.Does referral to specialist paediatric palliative care services reduce hospital admissions in oncology patients at the end of life? Br J Cancer, 2013; 108(6):1273–1279; doi: 10.1038/bjc.2013.89
18.
AgarMAA, CallaghanL, DooleyKA, et al.National Palliative Care Standards. Palliative Care Australia: Australia; 2018.
19.
ZimmermannK, SimonM, ScheinemannK, et al.Specialised paediatric PAlliativE CaRe: Assessing family, healthcare professionals and health system outcomes in a multi-site context of various care settings: SPhAERA study protocol. BMC Palliat Care, 2022; 21(1):188; doi: 10.1186/s12904-022-01089-x
20.
SoanesL, HargraveD, SmithL, et al.What are the experiences of the child with a brain tumour and their parents? Eur J Oncol Nurs, 2009; 13(4):255–261; doi: 10.1016/j.ejon.2009.03.009
21.
YoungK, CashionC, HassallT, et al.Supporting families through paediatric brain tumour: Unmet needs and suggestions for change. Psychooncology, 2023; 32(6):942–950; doi: 10.1002/pon.6136
22.
YamadaY, KobayashiD, TerashimaK, et al.Initial symptoms and diagnostic delay in children with brain tumors at a single institution in Japan. Neurooncol Pract, 2021; 8(1):60–67; doi: 10.1093/nop/npaa062
23.
CohenKJ, HeidemanRL, ZhouT, et al.Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: A report from the Children’s Oncology Group. Neuro Oncol, 2011; 13(4):410–416; doi: 10.1093/neuonc/noq205
24.
ValleroSG, BertinD, BassoME, et al.Diffuse intrinsic pontine glioma in children and adolescents: A single-center experience. Childs Nerv Syst, 2014; 30(6):1061–1066; doi: 10.1007/s00381-014-2359-x
25.
KlineC, FeltonE, AllenIE, et al.Survival outcomes in pediatric recurrent high-grade glioma: Results of a 20-year systematic review and meta-analysis. J Neurooncol, 2018; 137(1):103–110; doi: 10.1007/s11060-017-2701-8
26.
KayeEC, RubensteinJ, LevineD, et al.Pediatric palliative care in the community. CA Cancer J Clin, 2015; 65(4):316–333; doi: 10.3322/caac.21280
27.
CaparsoC, AppelJ, BenkertR. Dying concerns in young parents with advanced cancer (PWAC): A scoping review. Palliat Support Care, 2021; 19(1):93–102; doi: 10.1017/S1478951520000309
28.
SasakiH, BouesseauM-C, MarstonJ, et al.A scoping review of palliative care for children in low- and middle-income countries. BMC Palliat Care, 2017; 16(1):60; doi: 10.1186/s12904-017-0242-8
29.
Bernier CarneyKM, GoodrichG, LaoA, et al.Palliative care referral criteria and application in pediatric illness care: A scoping review. Palliat Med, 2023; 37(5):692–706; doi: 10.1177/02692163231163258
30.
WalkerM, NicolardiD, ChristopoulosT, et al.Hospital, hospice, or home: A scoping review of the importance of place in pediatric palliative care. Palliat Support Care, 2023; 21(5):925–934; doi: 10.1017/S1478951523000664
31.
YoungK, BowersA, BradfordN. Families’ experiences of child and adolescent brain tumor: A systematic review and synthesis of qualitative research. Psychooncology, 2021; 30(10):1643–1662; doi: 10.1002/pon.5745
32.
WoolfSH, GrolR, HutchinsonA, et al.Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines. BMJ, 1999; 318(7182):527–530; doi: 10.1136/bmj.318.7182.527
33.
PetersMGC, McInerneyP, MunnZ, et al.Scoping reviews In: JBI Manual for Evidence Synthesis. (AromatarisE MZ, ed.) JBI; 2020.
34.
BakhtaryMMM, RaspinS, VemuriS, SharmaP. Palliative care for children and adolescents with non-curative brain tumour: A scoping review protocol. Australia. 2023.
National Institute for Health and Care Excellence. 2023. Available from: https://www.nice.org.uk
37.
HarzingAW. Public or Perish. 2007.
38.
De ClercqE, GrotzerM, LandoltMA, et al.No wrong decisions in an all-wrong situation. A qualitative study on the lived experiences of families of children with diffuse intrinsic pontine glioma. Pediatr Blood Cancer, 2022; 69(9):e29792; doi: 10.1002/pbc.29792
39.
Team TE. EndNote. EndNote X9 ed. Clarivate: Philadelphia, PA; 2013.
40.
Covidence Systematic Review Software. 2023. Available from: www.covidence.org
41.
ArlandLC, Hendricks-FergusonVL, PearsonJ, et al.Development of an in-home standardized end-of-life treatment program for pediatric patients dying of brain tumors. J Spec Pediatr Nurs, 2013; 18(2):144–157; doi: 10.1111/jspn.12024
42.
BlackK, McDonaldC, WrenT, et al.Newly diagnosed high grade glioma and dipg: Collaborative efforts of pediatric neuro-oncology and palliative care. Neuro Oncol, 2016; 18(Suppl 3):iii138.2–iii138; doi: 10.1093/neuonc/now079.18
43.
Robles-CastroJ, Niembro-ZúñigaA, Ortiz-AzpilcuetaM, et al.Diffuse intrinsic pontine gliomas: First registry effort in Mexico. Pediatr Blood Cancer, 2023:e30431; doi: 10.1002/pbc.30431
44.
DeanerAE. Diffuse Intrinsic Pontine Glioma (DIPG): A Qualitative Study. 2017.
45.
HasanF, WeingartenK, RapoportA, et al.End-of-life care of children with malignant pontine tumours. Neuro-Oncol, 2016; 18(Supplement 3):iii62; doi: 10.1093/neuonc/now073.61
46.
HasanF, WeingartenK, RapoportA, et al.End-of-life care of children with diffuse intrinsic pontine glioma. J Neurooncol, 2018; 138(1):147–153; doi: 10.1007/s11060-018-2781-0
47.
Jagt-van KampenCT, van de WeteringMD, Schouten-van MeeterenAYN. The timing, duration, and management of symptoms of children with an incurable brain tumor: A retrospective study of the palliative phase. Neurooncol Pract, 2015; 2(2):70–77; doi: 10.1093/nop/npu038
48.
KuhlenM, HoellJ, BalzerS, et al.Symptoms and management of pediatric patients with incurable brain tumors in palliative home care. Eur J Paediatr Neurol, 2016; 20(2):261–269; doi: 10.1016/j.ejpn.2015.12.004
49.
MandrellBN, BakerJ, LevineD, et al.Children with minimal chance for cure: Parent proxy of the child’s health-related quality of life and the effect on parental physical and mental health during treatment. J Neurooncol, 2016; 129(2):373–381; doi: 10.1007/s11060-016-2187-9
50.
RobertR, RazviS, TricheLL, et al.Bereaved parent perspectives on end-of-life conversations in pediatric oncology. Children (Basel), 2022; 9(2):17; doi: 10.3390/children9020274
51.
YanagisawaT, TomonariS, KoheiF, et al.Home-based palliative care for children with recurrent and/or refractory central nervous system tumour. Pediatric Blood and Cancer, 2016; 63 (Supplement 3):S294; doi: 10.1002/pbc.26233
52.
WangZ, KhakooY. Palliative Care: Understanding Body Intactness in Chinese Culture (1935). AAN Enterprises; 2021.
53.
PearlmanL, ZelcerS, JohnstonDL. Palliative care for children with brain tumors. Pediatric Neuro-Oncology, 2015:289–298.
54.
BrockK, SnamanJ, KayeE, et al.Models of pediatric palliative oncology outpatient care - benefits, challenges, and opportunities. Pediatric Blood and Cancer, 2019; 66(Supplement 2):S197; doi: 10.1002/pbc.27713
55.
ColemanC, ChenK, LuA, et al.Interdisciplinary care of children with diffuse midline glioma. Neoplasia, 2023; 35:100851.
56.
Hendricks-FergusonVL, KaneJR, PradhanKR, et al.Evaluation of physician and nurse Dyad training procedures to deliver a palliative and end-of-life communication intervention to parents of children with a brain tumor. J Pediatr Oncol Nurs, 2015; 32(5):337–347; doi: 10.1177/1043454214563410
57.
Hendricks-FergusonVL, PradhanK, ShihCS, et al.Pilot evaluation of a palliative and end-of-life communication intervention for parents of children with a brain tumor. J Pediatr Oncol Nurs, 2017; 34(3):203–213; doi: 10.1177/1043454216676836
58.
KayeEC, BakerJN, BroniscerA. Management of diffuse intrinsic pontine glioma in children: Current and future strategies for improving prognosis. CNS Oncol, 2014; 3(6):421–431; doi: 10.2217/cns.14.47
59.
PapageorgiouGI, RazisED. CNS tumors in adolescents and young adults: The need for a holistic specialized approach. JCO Oncol Pract, 2020; 16(4):155–162; doi: 10.1200/JOP.18.00767
60.
LuS, QuinnM, VenteT. Hiding hospice: Culturally responsive care at pediatric end of life (CS329). J Pain and Symptom Manage, 2023; 65(5):e554.
61.
SisonJ, TranH, MargolA, et al.Palliative care options for a young adult patient with a diffuse intrinsic pontine glioma. Cureus, 2017; 9(8):e1580; doi: 10.7759/cureus.1580
62.
VitanzaNA, MonjeM. Diffuse intrinsic pontine glioma: From diagnosis to next-generation clinical trials. Curr Treat Options Neurol, 2019; 21(8):37; doi: 10.1007/s11940-019-0577-y
63.
BlionasA, GiakoumettisD, KlonouA, et al.Paediatric gliomas: Diagnosis, molecular biology and management. Ann Transl Med, 2018; 6(12):251; doi: 10.21037/atm.2018.05.11
64.
MethvenM. Ice cream for breakfast. Narrat Inq Bioeth, 2014; 4(1):31–33.
65.
HammerNM, HanssonH, PedersenLH, et al.Intersectoral collaboration in home-based end-of-life pediatric cancer care: A qualitative multiple-case study integrating families’ and professionals’ experiences. Palliat Med, 2023; 37(1):149–162; doi: 10.1177/02692163221135350
66.
MomberS. Palliative care for paediatric patients with brain tumours: It’s not all about the morphine. Neuro-oncol, 2016; 18(Supplement 3):iii135; doi: 10.1093/neuonc/now079.02
67.
RobinsonJE, HuskeyD, SchwartzJ, et al.The many roles of the rock: A qualitative inquiry into the roles and responsibilities of fathers of children with brain tumors. Children (Basel), 2019; 6(10):11; doi: 10.3390/children6100113
TabernaM, Gil MoncayoF, Jané-SalasE, et al.The Multidisciplinary Team (MDT) approach and quality of care. Front Oncol, 2020; 10:85; doi: 10.3389/fonc.2020.00085
73.
RosellL, AlexanderssonN, HagbergO, et al.Benefits, barriers and opinions on multidisciplinary team meetings: A survey in Swedish cancer care. BMC Health Serv Res, 2018; 18(1):249; doi: 10.1186/s12913-018-2990-4
74.
VerberneLM, Schouten-van MeeterenAY, BosmanDK, et al.Parental experiences with a paediatric palliative care team: A qualitative study. Palliat Med, 2017; 31(10):956–963; doi: 10.1177/0269216317692682
75.
ChanMH, BoopF, QaddoumiI. Challenges and opportunities to advance pediatric neuro-oncology care in the developing world. Childs Nerv Syst, 2015; 31(8):1227–1237; doi: 10.1007/s00381-015-2771-x
76.
FreemanCR, PerilongoG. Chemotherapy for brain stem gliomas. Childs Nerv Syst, 1999; 15(10):545–553; doi: 10.1007/s003810050542
77.
WingerA, KvarmeLG, LøylandB, et al.Family experiences with palliative care for children at home: A systematic literature review. BMC Palliat Care, 2020; 19(1):165; doi: 10.1186/s12904-020-00672-4
78.
BaenzigerPH, MoodyK. Palliative care for children with central nervous system malignancies. Bioengineering (Basel), 2018; 5(4); doi: 10.3390/bioengineering5040085
79.
InglinS, HornungR, BergstraesserE. Palliative care for children and adolescents in Switzerland: A needs analysis across three diagnostic groups. Eur J Pediatr, 2011; 170(8):1031–1038; doi: 10.1007/s00431-011-1398-5
80.
HsiaoJL, EvanEE, ZeltzerLK. Parent and child perspectives on physician communication in pediatric palliative care. Palliat Support Care, 2007; 5(4):355–365; doi: 10.1017/s1478951507000557
81.
WeidnerNJ, CameronM, LeeRC, et al.End-of-life care for the dying child: What matters most to parents. J Palliat Care, 2011; 27(4):279–286.
82.
NyekoR, KambuguJB, AngomR, et al.The clinicopathological profile and value of multidisciplinary management of pediatric brain tumors in a low-income setting. Pediatr Hematol Oncol, 2023; 40(3):267–280; doi: 10.1080/08880018.2022.2140861
83.
CastorC, LandgrenK, HanssonH, et al.A possibility for strengthening family life and health: Family members’ lived experience when a sick child receives home care in Sweden. Health Soc Care Community, 2018; 26(2):224–231; doi: 10.1111/hsc.12512
84.
HechlerT, BlankenburgM, FriedrichsdorfSJ, et al.Parents’ perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer. Klin Padiatr, 2008; 220(3):166–174; doi: 10.1055/s-2008-1065347
85.
VickersJL, CarlisleC. Choices and control: Parental experiences in pediatric terminal home care. J Pediatr Oncol Nurs, 2000; 17(1):12–21; doi: 10.1177/104345420001700103
86.
RallisonLB, Raffin-BouchalS. Living in the in-between: Families caring for a child with a progressive neurodegenerative illness. Qual Health Res, 2013; 23(2):194–206; doi: 10.1177/1049732312467232
87.
BowerKA, AugerJA, BrownS, et al.Integration of neuro-oncology and pediatric palliative care at diagnosis in the outpatient setting. (FR436). J Pain and Symptom Management, 2020; 59(2):464–465; doi: 10.1016/j.jpainsymman.2019.12.145
88.
SchieberGJ, PoullierJP, GreenwaldLM. Health care systems in twenty-four countries. Health Aff (Millwood), 1991; 10(3):22–38; doi: 10.1377/hlthaff.10.3.22
89.
BarnesAJ, UnruhLY, RosenauP, et al.Health System in the USA. In: Health Care Systems and Policies. (van GinnekenE, BusseReds) Springer US: Boston, MA; 2017, pp.1–33.
PapanicolasI, WoskieLR, JhaAK. Health care spending in the United States and other high-income countries. JAMA, 2018; 319(10):1024–1039; doi: 10.1001/jama.2018.1150
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
